Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | 1,098,068 | reported | 28 Feb 2024 | tx 130+10,519,452−1,362,214 |
| Relay Therapeutics, Inc. | 207,931 | reported | 04 Nov 2025 | tx 1+207,931 |
| Blueprint Medicines Corp | 0 | reported | 17 Jul 2025 | tx 42+112,161−117,461 |
| Verve Therapeutics, Inc. | 0 | reported | 25 Jul 2025 | tx 6+235,981−178,339 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Nov 2025 | GRANT_AWARD | Relay Therapeutics, Inc. | 207,931 | 0.00 USD | deriv |
| 25 Jul 2025 | OTHER | Verve Therapeutics, Inc. | 136,139 | — | deriv |
| 25 Jul 2025 | OTHER | Verve Therapeutics, Inc. | 42,200 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 6,144 | — | |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 5,300 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 4,570 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 5,300 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 11,818 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 10,909 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 10,909 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 4,875 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 3,188 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 4,500 | — | deriv |
| 18 Jun 2025 | GRANT_AWARD | Blueprint Medicines Corp | 3,902 | 12812.00 USD | |
| 05 Jun 2025 | GRANT_AWARD | Verve Therapeutics, Inc. | 42,200 | 0.00 USD | deriv |
| 20 Nov 2024 | EXERCISE | Blueprint Medicines Corp | 7,500 | 69.79 USD | |
| 20 Nov 2024 | EXERCISE | Blueprint Medicines Corp | 1,312 | 76.24 USD | |
| 21 Nov 2024 | SALE | Blueprint Medicines Corp | 9,824 | 94.87 USD | |
| 20 Nov 2024 | SALE | Blueprint Medicines Corp | 5,287 | 94.24 USD | |
| 20 Nov 2024 | SALE | Blueprint Medicines Corp | 213 | 94.99 USD | |
| 20 Nov 2024 | SALE | Blueprint Medicines Corp | 4,500 | 93.15 USD | |
| 20 Nov 2024 | EXERCISE | Blueprint Medicines Corp | 7,500 | 0.00 USD | deriv |
| 20 Nov 2024 | EXERCISE | Blueprint Medicines Corp | 1,312 | 0.00 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Verve Therapeutics, Inc. | 136,139 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | Blueprint Medicines Corp | 2,242 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 22 Jun 2023.